Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | PPARD | Q03181 | 4/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10949517 | 1.00 | DGKA (0.52) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL6889455 | 1.00 | DGKA (0.52) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL11639759 | 1.00 | DGKA (0.52) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL5070013 | 1.00 | DGKA (0.52) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL9565427 | 1.00 | DGKA (0.52) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL6535867 | 0.98 | DGKA (0.48) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL6526444 | 0.92 | ALDH1A1 (0.50) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL28181086 | 0.90 | DGKA (0.53) | DGKALMNAPAMALDH1A1MAPT | |
| SCHEMBL2779344 | 0.90 | CNR2 (0.55) | DGKALMNAMAPTPPARGPPARD | |
| SCHEMBL28199038 | 0.88 | DGKA (0.50) | DGKALMNAPAMALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115014886-A | Method for preparing measurement sample, method for analyzing measurement sample, reagent, and kit | 希森美康株式会社 | 2022-09-06 | — | — | CN | claimed |
| WO-2020004535-A1 | SENSOR CHIP FOR HIGH-SENSITIVITY DETECTION OF CELLS, ETC. | 株式会社堀場製作所 | 2020-01-02 | — | — | WO | claimed |
| CN-111936837-B | QMAX assay and use | 上海宜晟生物科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-11940382-B2 | Assay with amplification | ESSENLIX CORPORATION (US) | 2024-03-26 | — | — | US | disclosed |
| US-11892746-B1 | Super system on chip | MAZED MOHAMMAD A (US) | 2024-02-06 | — | — | US | disclosed |
| US-11885887-B1 | Imaging subsystem | MAZED MOHAMMAD A (US) | 2024-01-30 | — | — | US | disclosed |
| US-11320588-B1 | Super system on chip | MAZED MOHAMMAD A (US) | 2022-05-03 | — | — | US | disclosed |
| CN-111936837-A | QMAX determination and uses | ESSENLIX公司 | 2020-11-13 | — | — | CN | disclosed |
| US-20200319176-A1 | QMAX ASSAYS AND APPLICATIONS | ESSENLIX CORPORATION (US) | 2020-10-08 | — | — | US | disclosed |
| US-20200225161-A1 | ASSAY WITH AMPLIFICATION | ESSENLIX CORPORATION (US) | 2020-07-16 | — | — | US | disclosed |
| US-10656149-B2 | Analyte detection enhancement by targeted immobilization, surface amplification, and pixelated reading and analysis | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2020-05-19 | — | — | US | disclosed |
| WO-2013154770-A1 | ULTRA-SENSITIVE SENSOR | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-10-17 | — | — | WO | disclosed |
| US-20130171712-A1 | CULTURE METHOD AND CULTURE DEVICE | UNIVERSITY OF TSUKUBA (JP) | 2013-07-04 | — | — | US | disclosed |
| CN-102307885-A | Method for introducing functional groups to the surface of a substance | NAT UNIV KANGNUNG WONJU | 2012-01-04 | — | — | CN | disclosed |
| US-8067053-B2 | Method for selective immobilization of macromolecules on self assembled monolayer surfaces | BATTELLE MEMORIAL INSTITUTE (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110082279-A1 | Chemiluminescent Compounds | GEN-PROBE INCORPORATED (US) | 2011-04-07 | — | — | US | disclosed |
| US-20100285514-A1 | ELECTROCHEMICAL BIOSENSOR | PURDUE RESEARCH FOUNDATION | 2010-11-11 | — | — | US | disclosed |
| EP-1658503-B1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECH RES LTD (GB) | 2009-11-18 | — | — | EP | disclosed |
| US-20090280264-A1 | Method for selective immobilization of macromolecules on self assembled monolayer surfaces | U.S. DEPARTMENT OF ENERGY | 2009-11-12 | — | — | US | disclosed |
| US-20070166759-A1 | Chemiluminescent compounds | GEN-PROBE CARDIFF, LTD. (GB) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166759-A1 | Chemiluminescent compounds | CBR3, CBR1, LTC4S | DGKA 4102/4885LMNA 202/4885PAM 753/4885 |
| US-20110082279-A1 | Chemiluminescent Compounds | CBR3, LTC4S, CBR1 | DGKA 4229/4885LMNA 131/4885PAM 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.